0

Close
 
Upcoming Allied Market Research
2023
E Coli Testing Market

E coli Testing Market: Global Opportunity Analysis and Industry Forecast, 2019-2026 Market

LS : Diagnostics and Biotech
Report Code: A11131
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the E Coli Testing Market

Request Now !

Escherichia coli or E. coli is specified to be a bacterium that generally lives in the guts of humans and animals. There are some types of E. coli, which are an important part of a healthy human intestinal system. Moreover, others are pathogenic and may cause illness or diarrhea. Diarrhea, hence caused, can be transmitted through contaminated water and food or even through contact with animals or other people. There are various Pathogenic E. coli strains, which are classified according to the pathotypes. Almost six pathotypes of E. coli are there associated with diarrhea and are referred to as diarrhea genic E. coli. Major signs and symptoms of the E. coli infection are diarrhea, abdominal pain, and nausea and vomiting. The cases of E. coli infection are usually confirmed by the detection of bacteria in stool samples of the infected individuals. It is mainly found in contaminated food or contaminated water, including untreated drinking water, and the feces of infected people. Furthermore, the bacterium is also present on the surface of animals, mainly sheep, cows, and goats.

COVID-19 scenario analysis:

During the early phase of the outbreak of the coronavirus disease-2, the diagnostic kits for the testing of the virus were unavailable, which led to global increase in the need for the major leaders to invest upon the R&D of the kits required. The kits which were available for the other viral strains to be tested were allowed to be used, but were inefficient. This unavailability of specific COVID-19 diagnostic tests brought lucrative opportunities for the manufacturers of such diagnostic procedures, to introduce their COVID-19 diagnostic kits. The key leaders as well as some start-ups from various countries took maximum advantage of this opportunity and introduced COVID-19 diagnostics kits into the market. These players achieved superiority over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, aids them in maintaining their revenues in such a crisis.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The market is driven by factors such as, rise in prevalence of diarrhea and Hemolytic Uremic Syndrome (HUS), and increase in number of water-borne disease, especially are being found more in under developed and the developing countries, would boost the industry in the forecast period. The global concern towards the improvement of quality of life has led to the need for the timely testing of the food and water that are consumed and also avoid the ingestion of the contaminated products henceforth, which is anticipated to help the industry grow in the coming years. However, the reliability of the testing kits, may hamper the growth in the commenced period.

New product advancements to flourish the market

In September 2017, PLOS ONE, developed a novel paper based DipTest device, similar to a litmus test, for detection of E. coli bacteria in water samples. This device is easy to fabricate and simple to test the water samples.

In July 2019, Bio-Rad will be introducing a test kit that can precisely detect Shiga toxin-producing E. coli pathogens in the food products, including meat and poultry. This dd-Check STEC Solution utilizes ddPCR technology to distinguish double-positive linked, true virulence genes in a sample from samples containing single-positive or unlinked virulence genes, minimizing the number of false-positive Shiga toxin-producing Escherichia coli (STEC) results. The detection and linkage verification of targets in a single bacterium enhances the precision of pathogenic E. coli testing.

Surge in awareness of disease caused due to E. coli to boost the market

In 2011, due to the E. coli outbreak, the World health Organization supported the coordination of collection of information, sharing and collaboration through International Health Regulations and the International Food Safety Authorities Network (INFOSAN) globally. It worked closely with national health authorities and international partners, in order to provide technical assistance and the latest information on outbreaks.

Key benefits of the report:

  • This study presents the analytical depiction of the global E. coli testing industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global E. coli testing market share.
  • The current market is quantitatively analyzed to highlight the global E. coli testing market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global E. coli testing market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the E. coli testing market research report:

  • Which are the leading market players active in the E. coli testing market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in tasking further strategic steps?

 E coli Testing Market: Global Opportunity Analysis and Industry Forecast, 2019–2026 Report Highlights

Aspects Details
By Clinical Testing Method
  • Enzyme Immunoassays (EIA)
  • Polymerase Chain Reaction (PCR) Tests
  • Others
By Enviornment Testing
  • Enzyme Substrate Methods
  • Membrane Filtration (MF)
  • Multiple Tube Fermentation (MTF)
By End User
  • Clinical Testing Methods
  • Diagnostic Laboratories
  • Hospital Physician Offices
  • Environmental Testing
  • Bottled Water Suppliers
  • Home and Drinking Water Suppliers
  • Others (Government Agencies, etc.) Waste Water Treatment Organizations
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Pro-Lab Diagnostics, Inc., IDEXX Laboratories, Inc., Bio-Rad Laboratories, Inc., Meridian Bioscience, Inc, Becton, Dickinson and Company, Alere Inc, BioMerieux Inc., CPI International, Inc, Thermo Fisher Scientific, Inc.
Other Players NanoLogix, Inc.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: E COLI TESTING MARKET, BY CLINICAL TESTING METHOD

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Clinical Testing Method

    • 4.2. Enzyme Immunoassays (EIA)

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Polymerase Chain Reaction (PCR) Tests

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Others

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: E COLI TESTING MARKET, BY ENVIORNMENT TESTING

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Enviornment Testing

    • 5.2. Enzyme Substrate Methods

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Membrane Filtration (MF)

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Multiple Tube Fermentation (MTF)

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: E COLI TESTING MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Clinical Testing Methods

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Diagnostic Laboratories

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Hospital Physician Offices

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Environmental Testing

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Bottled Water Suppliers

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Home And Drinking Water Suppliers

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

    • 6.8. Others (Government Agencies, Etc.) Waste Water Treatment Organizations

      • 6.8.1. Key Market Trends, Growth Factors and Opportunities

      • 6.8.2. Market Size and Forecast, By Region

      • 6.8.3. Market Share Analysis, By Country

  • CHAPTER 7: E COLI TESTING MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Clinical Testing Method

      • 7.2.3. Market Size and Forecast, By Enviornment Testing

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. E Coli Testing Market

        • 7.2.6.1. Market Size and Forecast, By Clinical Testing Method
        • 7.2.6.2. Market Size and Forecast, By Enviornment Testing
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada E Coli Testing Market

        • 7.2.7.1. Market Size and Forecast, By Clinical Testing Method
        • 7.2.7.2. Market Size and Forecast, By Enviornment Testing
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico E Coli Testing Market

        • 7.2.8.1. Market Size and Forecast, By Clinical Testing Method
        • 7.2.8.2. Market Size and Forecast, By Enviornment Testing
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Clinical Testing Method

      • 7.3.3. Market Size and Forecast, By Enviornment Testing

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France E Coli Testing Market

        • 7.3.6.1. Market Size and Forecast, By Clinical Testing Method
        • 7.3.6.2. Market Size and Forecast, By Enviornment Testing
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany E Coli Testing Market

        • 7.3.7.1. Market Size and Forecast, By Clinical Testing Method
        • 7.3.7.2. Market Size and Forecast, By Enviornment Testing
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy E Coli Testing Market

        • 7.3.8.1. Market Size and Forecast, By Clinical Testing Method
        • 7.3.8.2. Market Size and Forecast, By Enviornment Testing
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain E Coli Testing Market

        • 7.3.9.1. Market Size and Forecast, By Clinical Testing Method
        • 7.3.9.2. Market Size and Forecast, By Enviornment Testing
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK E Coli Testing Market

        • 7.3.10.1. Market Size and Forecast, By Clinical Testing Method
        • 7.3.10.2. Market Size and Forecast, By Enviornment Testing
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia E Coli Testing Market

        • 7.3.11.1. Market Size and Forecast, By Clinical Testing Method
        • 7.3.11.2. Market Size and Forecast, By Enviornment Testing
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe E Coli Testing Market

        • 7.3.12.1. Market Size and Forecast, By Clinical Testing Method
        • 7.3.12.2. Market Size and Forecast, By Enviornment Testing
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Clinical Testing Method

      • 7.4.3. Market Size and Forecast, By Enviornment Testing

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China E Coli Testing Market

        • 7.4.6.1. Market Size and Forecast, By Clinical Testing Method
        • 7.4.6.2. Market Size and Forecast, By Enviornment Testing
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan E Coli Testing Market

        • 7.4.7.1. Market Size and Forecast, By Clinical Testing Method
        • 7.4.7.2. Market Size and Forecast, By Enviornment Testing
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India E Coli Testing Market

        • 7.4.8.1. Market Size and Forecast, By Clinical Testing Method
        • 7.4.8.2. Market Size and Forecast, By Enviornment Testing
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea E Coli Testing Market

        • 7.4.9.1. Market Size and Forecast, By Clinical Testing Method
        • 7.4.9.2. Market Size and Forecast, By Enviornment Testing
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia E Coli Testing Market

        • 7.4.10.1. Market Size and Forecast, By Clinical Testing Method
        • 7.4.10.2. Market Size and Forecast, By Enviornment Testing
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand E Coli Testing Market

        • 7.4.11.1. Market Size and Forecast, By Clinical Testing Method
        • 7.4.11.2. Market Size and Forecast, By Enviornment Testing
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia E Coli Testing Market

        • 7.4.12.1. Market Size and Forecast, By Clinical Testing Method
        • 7.4.12.2. Market Size and Forecast, By Enviornment Testing
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia E Coli Testing Market

        • 7.4.13.1. Market Size and Forecast, By Clinical Testing Method
        • 7.4.13.2. Market Size and Forecast, By Enviornment Testing
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific E Coli Testing Market

        • 7.4.14.1. Market Size and Forecast, By Clinical Testing Method
        • 7.4.14.2. Market Size and Forecast, By Enviornment Testing
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Clinical Testing Method

      • 7.5.3. Market Size and Forecast, By Enviornment Testing

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil E Coli Testing Market

        • 7.5.6.1. Market Size and Forecast, By Clinical Testing Method
        • 7.5.6.2. Market Size and Forecast, By Enviornment Testing
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa E Coli Testing Market

        • 7.5.7.1. Market Size and Forecast, By Clinical Testing Method
        • 7.5.7.2. Market Size and Forecast, By Enviornment Testing
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia E Coli Testing Market

        • 7.5.8.1. Market Size and Forecast, By Clinical Testing Method
        • 7.5.8.2. Market Size and Forecast, By Enviornment Testing
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE E Coli Testing Market

        • 7.5.9.1. Market Size and Forecast, By Clinical Testing Method
        • 7.5.9.2. Market Size and Forecast, By Enviornment Testing
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina E Coli Testing Market

        • 7.5.10.1. Market Size and Forecast, By Clinical Testing Method
        • 7.5.10.2. Market Size and Forecast, By Enviornment Testing
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA E Coli Testing Market

        • 7.5.11.1. Market Size and Forecast, By Clinical Testing Method
        • 7.5.11.2. Market Size and Forecast, By Enviornment Testing
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Thermo Fisher Scientific, Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Meridian Bioscience, Inc

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Becton, Dickinson And Company

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. IDEXX Laboratories, Inc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. CPI International, Inc

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Bio-Rad Laboratories, Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Pro-Lab Diagnostics, Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Alere Inc

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. BioMerieux Inc.

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL E COLI TESTING MARKET, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL E COLI TESTING MARKET FOR ENZYME IMMUNOASSAYS (EIA), BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL E COLI TESTING MARKET FOR POLYMERASE CHAIN REACTION (PCR) TESTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL E COLI TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL E COLI TESTING MARKET, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL E COLI TESTING MARKET FOR ENZYME SUBSTRATE METHODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL E COLI TESTING MARKET FOR MEMBRANE FILTRATION (MF), BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL E COLI TESTING MARKET FOR MULTIPLE TUBE FERMENTATION (MTF), BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL E COLI TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL E COLI TESTING MARKET FOR CLINICAL TESTING METHODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL E COLI TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL E COLI TESTING MARKET FOR HOSPITAL PHYSICIAN OFFICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL E COLI TESTING MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL E COLI TESTING MARKET FOR BOTTLED WATER SUPPLIERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL E COLI TESTING MARKET FOR HOME AND DRINKING WATER SUPPLIERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL E COLI TESTING MARKET FOR OTHERS (GOVERNMENT AGENCIES, ETC.) WASTE WATER TREATMENT ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL E COLI TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA E COLI TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 22. U.S. E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 23. U.S. E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 24. U.S. E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. CANADA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 26. CANADA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 27. CANADA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE E COLI TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 40. GERMANY E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 41. ITALY E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 42. ITALY E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 43. ITALY E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. UK E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 48. UK E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 49. UK E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 51. RUSSIA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 52. RUSSIA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 55. REST OF EUROPE E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC E COLI TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 59. ASIA-PACIFIC E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 60. CHINA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 61. CHINA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 62. CHINA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 64. JAPAN E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 65. JAPAN E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 66. INDIA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 67. INDIA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 68. INDIA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 71. SOUTH KOREA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 73. AUSTRALIA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 74. AUSTRALIA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 76. THAILAND E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 77. THAILAND E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 79. MALAYSIA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 80. MALAYSIA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 82. INDONESIA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 83. INDONESIA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA E COLI TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 89. LAMEA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 90. LAMEA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 92. BRAZIL E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 93. BRAZIL E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH AFRICA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 98. SAUDI ARABIA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 99. SAUDI ARABIA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. UAE E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 101. UAE E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 102. UAE E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 104. ARGENTINA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 105. ARGENTINA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA E COLI TESTING, BY CLINICAL TESTING METHOD, 2022-2032 ($MILLION)
  • TABLE 107. REST OF LAMEA E COLI TESTING, BY ENVIORNMENT TESTING, 2022-2032 ($MILLION)
  • TABLE 108. REST OF LAMEA E COLI TESTING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 109. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 110. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 111. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
  • TABLE 112. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
  • TABLE 113. THERMO FISHER SCIENTIFIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. MERIDIAN BIOSCIENCE, INC: KEY EXECUTIVES
  • TABLE 115. MERIDIAN BIOSCIENCE, INC: COMPANY SNAPSHOT
  • TABLE 116. MERIDIAN BIOSCIENCE, INC: OPERATING SEGMENTS
  • TABLE 117. MERIDIAN BIOSCIENCE, INC: PRODUCT PORTFOLIO
  • TABLE 118. MERIDIAN BIOSCIENCE, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 120. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 121. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 122. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 123. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. IDEXX LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 125. IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 126. IDEXX LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 127. IDEXX LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 128. IDEXX LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. CPI INTERNATIONAL, INC: KEY EXECUTIVES
  • TABLE 130. CPI INTERNATIONAL, INC: COMPANY SNAPSHOT
  • TABLE 131. CPI INTERNATIONAL, INC: OPERATING SEGMENTS
  • TABLE 132. CPI INTERNATIONAL, INC: PRODUCT PORTFOLIO
  • TABLE 133. CPI INTERNATIONAL, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 135. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 136. BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 137. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 138. BIO-RAD LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. PRO-LAB DIAGNOSTICS, INC.: KEY EXECUTIVES
  • TABLE 140. PRO-LAB DIAGNOSTICS, INC.: COMPANY SNAPSHOT
  • TABLE 141. PRO-LAB DIAGNOSTICS, INC.: OPERATING SEGMENTS
  • TABLE 142. PRO-LAB DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
  • TABLE 143. PRO-LAB DIAGNOSTICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. ALERE INC: KEY EXECUTIVES
  • TABLE 145. ALERE INC: COMPANY SNAPSHOT
  • TABLE 146. ALERE INC: OPERATING SEGMENTS
  • TABLE 147. ALERE INC: PRODUCT PORTFOLIO
  • TABLE 148. ALERE INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. BIOMERIEUX INC.: KEY EXECUTIVES
  • TABLE 150. BIOMERIEUX INC.: COMPANY SNAPSHOT
  • TABLE 151. BIOMERIEUX INC.: OPERATING SEGMENTS
  • TABLE 152. BIOMERIEUX INC.: PRODUCT PORTFOLIO
  • TABLE 153. BIOMERIEUX INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL E COLI TESTING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL E COLI TESTING MARKET
  • FIGURE 3. SEGMENTATION E COLI TESTING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN E COLI TESTING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALE COLI TESTING MARKET
  • FIGURE 11. E COLI TESTING MARKET SEGMENTATION, BY BY CLINICAL TESTING METHOD
  • FIGURE 12. E COLI TESTING MARKET FOR ENZYME IMMUNOASSAYS (EIA), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. E COLI TESTING MARKET FOR POLYMERASE CHAIN REACTION (PCR) TESTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. E COLI TESTING MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. E COLI TESTING MARKET SEGMENTATION, BY BY ENVIORNMENT TESTING
  • FIGURE 16. E COLI TESTING MARKET FOR ENZYME SUBSTRATE METHODS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. E COLI TESTING MARKET FOR MEMBRANE FILTRATION (MF), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. E COLI TESTING MARKET FOR MULTIPLE TUBE FERMENTATION (MTF), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. E COLI TESTING MARKET SEGMENTATION, BY BY END USER
  • FIGURE 20. E COLI TESTING MARKET FOR CLINICAL TESTING METHODS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. E COLI TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. E COLI TESTING MARKET FOR HOSPITAL PHYSICIAN OFFICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. E COLI TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. E COLI TESTING MARKET FOR BOTTLED WATER SUPPLIERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. E COLI TESTING MARKET FOR HOME AND DRINKING WATER SUPPLIERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. E COLI TESTING MARKET FOR OTHERS (GOVERNMENT AGENCIES, ETC.) WASTE WATER TREATMENT ORGANIZATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 31. COMPETITIVE DASHBOARD
  • FIGURE 32. COMPETITIVE HEATMAP: E COLI TESTING MARKET
  • FIGURE 33. Top player positioning, 2022
  • FIGURE 34. THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. MERIDIAN BIOSCIENCE, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. MERIDIAN BIOSCIENCE, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. MERIDIAN BIOSCIENCE, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. BECTON, DICKINSON AND COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. IDEXX LABORATORIES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. IDEXX LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. IDEXX LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. CPI INTERNATIONAL, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. CPI INTERNATIONAL, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. CPI INTERNATIONAL, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. BIO-RAD LABORATORIES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. BIO-RAD LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. PRO-LAB DIAGNOSTICS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. PRO-LAB DIAGNOSTICS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. PRO-LAB DIAGNOSTICS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. ALERE INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. ALERE INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. ALERE INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. BIOMERIEUX INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. BIOMERIEUX INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. BIOMERIEUX INC.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
E Coli Testing Market

Start reading.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers